There’s no reason to believe those changes aren’t needed to work more effectively though, especially if it’s trying to be classified as an ADHD medication. Changing one molecule really can fundamentally change a drug, if it’s the right molecule changed the right way, it’s not inherently a cash grab, there’s not enough info here about the chemistry and its applications to make that call
This is really interesting. As I was reading the article I was wondering how they were going to wring money out of it, as amlodipine is off patent. Then I got to this part:
Classic big pharma. Slightly tweak an existing drug in an insignificant way so that you can get a new patent on it and charge exorbitant prices.
save